H. Lundbeck A/S (HLUN-B.CO) has a MoatMap StockRank of 99/100 based on Quality (70/100), Value (72/100), and Momentum (60/100) factor scores. The current signal is STRONG BUY.
| Price | $6.58 |
| Market Cap | $6.5B |
| P/E (TTM) | 11.26 |
| P/E (Forward) | 6.91 |
| Price/Book | 1.69 |
| Return on Equity | 14.9% |
| Return on Invested Capital | 11.6% |
| Debt/Equity | 42.64 |
| Gross Margin | 82.4% |
| Operating Margin | 30.2% |
| Revenue Growth | 14.3% |
| Dividend Yield | 2.7% |
| Free Cash Flow | $120M |
H. Lundbeck A/S operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (Denmark).